India beefs up regulatory system and adds new office in Mumbai
This article was originally published in Scrip
Executive Summary
India has launched a series of initiatives to strengthen its drug regulatory framework, including more than doubling its regulatory manpower and laying down guidelines for better monitoring of clinical trials.